Cellular Biomedicine Group Inc (CBMG):企業の財務・戦略的SWOT分析

◆英語タイトル:Cellular Biomedicine Group Inc (CBMG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH451369FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of knee osteoarthritis, cancer, asthma and chronic obstructive pulmonary diseases. It offers treatment protocol services such as orthopaedic diseases including osteoarthritis and tissue damage; and other indications. CBMG utilizes proprietary cell based technologies to produce raw material, manufacture cells, and conduct cell banking and distribution. The firm has operations in Hong Kong, China and the US. CBMG is headquartered in Cupertino, California, the US.

Cellular Biomedicine Group Inc Key Recent Developments

Feb 19,2021: 14:55 ET Cellular Biomedicine Group, Inc. Announces Completion of Merger Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”) today announced the completion of the merger (the “Merger”) of the Company…
Feb 08,2021: Cellular Biomedicine Group, Inc. Stockholders Approve Merger
Nov 09,2020: Cellular Biomedicine Group reports Q3 2020 financial results and business highlights
Aug 12,2020: Cellular Biomedicine Group (CBMG) reports Q2, H1 2020 financial results and business highlights
Jul 13,2020: Cellular Biomedicine Group (CBMG) hosts R&D showcase and provides updates to clinical programs

This comprehensive SWOT profile of Cellular Biomedicine Group Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cellular Biomedicine Group Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cellular Biomedicine Group Inc – Key Information
Cellular Biomedicine Group Inc – Overview
Cellular Biomedicine Group Inc – Key Employees
Cellular Biomedicine Group Inc – Key Employee Biographies
Cellular Biomedicine Group Inc – Key Operational Heads
Cellular Biomedicine Group Inc – Major Products and Services
Cellular Biomedicine Group Inc – History
Cellular Biomedicine Group Inc – Company Statement
Cellular Biomedicine Group Inc – Locations And Subsidiaries
Cellular Biomedicine Group Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cellular Biomedicine Group Inc – Business Description
Cellular Biomedicine Group Inc – Corporate Strategy
Cellular Biomedicine Group Inc – SWOT Analysis
SWOT Analysis – Overview
Cellular Biomedicine Group Inc – Strengths
Cellular Biomedicine Group Inc – Weaknesses
Cellular Biomedicine Group Inc – Opportunities
Cellular Biomedicine Group Inc – Threats
Cellular Biomedicine Group Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cellular Biomedicine Group Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cellular Biomedicine Group Inc, Key Information
Cellular Biomedicine Group Inc, Key Ratios
Cellular Biomedicine Group Inc, Share Data
Cellular Biomedicine Group Inc, Major Products and Services
Cellular Biomedicine Group Inc, History
Cellular Biomedicine Group Inc, Key Employees
Cellular Biomedicine Group Inc, Key Employee Biographies
Cellular Biomedicine Group Inc, Key Operational Heads
Cellular Biomedicine Group Inc, Other Locations
Cellular Biomedicine Group Inc, Subsidiaries
Cellular Biomedicine Group Inc, Key Competitors
Cellular Biomedicine Group Inc, SWOT Analysis
Cellular Biomedicine Group Inc, Ratios based on current share price
Cellular Biomedicine Group Inc, Annual Ratios
Cellular Biomedicine Group Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cellular Biomedicine Group Inc (CBMG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kosmos Energy Ltd (KOS):石油・ガス:M&Aディール及び事業提携情報
    Summary Kosmos Energy Ltd. (Kosmos) is an independent oil and gas exploration and production company. Its primary areas of operation are frontier and emerging areas along the Atlantic Margin. The company’s asset portfolio includes existing production and development projects offshore Ghana, discover …
  • Aabar Investments:企業の戦略的SWOT分析
    Aabar Investments - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Salter Labs:医療機器:M&Aディール及び事業提携情報
    Summary Salter Labs (Salter) is a medical device company that offers HME, home, and acute care products. The company offers products such as whisper and silhouette cannula, swivel connector, static connector and humidifier tubing, among others. It also provides visible tubing, petite cannula sensiti …
  • Neusoft Corporation (600718):企業の財務・戦略的SWOT分析
    Neusoft Corporation (600718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Amil Assistencia Medica Internacional S/A:企業の戦略・SWOT・財務情報
    Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report Summary Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Interprotein Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Interprotein Corp (Interprotein) is a drug development company that develops active modulators for protein-protein interaction (PPI) targets. The company offers products such as IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E …
  • Patterson Companies, Inc.
    Patterson Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Patterson Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ping An Insurance (Group) Company of China, Ltd.:企業のM&A・事業提携・投資動向
    Ping An Insurance (Group) Company of China, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ping An Insurance (Group) Company of China, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Empresa Electrica Corani SA (COR1U):電力:M&Aディール及び事業提携情報
    Summary Empresa Electrica Corani SA (Empresa Electrica), a subsidiary of Empresa Nacional de Electricidad Bolivia, is a renewable energy company that develops and operates hydroelectric power plants and wind farms. The company offers operation and maintenance, project development, and technical serv …
  • U.S. Energy Corp (USEG):企業の財務・戦略的SWOT分析
    Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It operates its oil and gas prospects located in the Williston Basin of North Dakota, the Eagl …
  • Isetan Mitsukoshi Holdings Ltd.:戦略・SWOT・企業財務分析
    Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bio-Rad Laboratories, Inc.:企業の戦略・SWOT・財務分析
    Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Polski Koncern Naftowy Orlen SA (PKN):石油・ガス:M&Aディール及び事業提携情報
    Summary Polski Koncern Naftowy Orlen SA (PKN Orlen) is an integrated oil and gas company. It explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. Its product portf …
  • Al Mouwasat Medical Services Company (4002):企業の財務・戦略的SWOT分析
    Summary Al Mouwasat Medical Services Company (Mouwasat Medical) is a healthcare service provider that provides health and skincare services. The centre offers services in health care, skin care, and fertility treatment. It provides clinical pharmacy services such as verifying dosages appropriateness …
  • OGE Energy Corp:企業の戦略・SWOT・財務情報
    OGE Energy Corp - Strategy, SWOT and Corporate Finance Report Summary OGE Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Investimentos, Participacoes e Gestao SA (INA):企業の財務・戦略的SWOT分析
    Investimentos, Participacoes e Gestao SA (INA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Westport Fuel Systems Inc.:企業のM&A・事業提携・投資動向
    Westport Fuel Systems Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westport Fuel Systems Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • PKB Privatbank SA:企業の戦略・SWOT・財務情報
    PKB Privatbank SA - Strategy, SWOT and Corporate Finance Report Summary PKB Privatbank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Curetis NV (CURE)-医療機器分野:企業M&A・提携分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, im …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆